{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T04:42:38Z","timestamp":1768365758767,"version":"3.49.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2016,8,2]],"date-time":"2016-08-02T00:00:00Z","timestamp":1470096000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["SFB-TR128"],"award-info":[{"award-number":["SFB-TR128"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005713","name":"Technical University of Munich","doi-asserted-by":"crossref","award":["KKF Fellowship"],"award-info":[{"award-number":["KKF Fellowship"]}],"id":[{"id":"10.13039\/501100005713","id-type":"DOI","asserted-by":"crossref"}]},{"name":"German Ministry for Education and Research","award":["Control-MS, 01GI0917"],"award-info":[{"award-number":["Control-MS, 01GI0917"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1007\/s00415-016-8237-6","type":"journal-article","created":{"date-parts":[[2016,8,2]],"date-time":"2016-08-02T07:48:14Z","timestamp":1470124094000},"page":"2105-2113","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Higher frequencies of HLA DQB1*05:01 and anti-glycosphingolipid antibodies in a cluster of severe Guillain\u2013Barr\u00e9 syndrome"],"prefix":"10.1007","volume":"263","author":[{"given":"L.","family":"Schirmer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Worthington","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U.","family":"Solloch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Loleit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Grummel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Lakdawala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Grant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Wassmuth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. H.","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Gebhardt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T. F. M.","family":"Andlauer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Sauter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Berthele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. P.","family":"Lunn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernhard","family":"Hemmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,8,2]]},"reference":[{"key":"8237_CR1","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1002\/ana.410400209","volume":"40","author":"BC Jacobs","year":"1996","unstructured":"Jacobs BC, van Doorn PA, Schmitz PI et al (1996) Campylobacter jejuni infections and anti-GM1 antibodies in Guillain\u2013Barr\u00e9 syndrome. Ann Neurol 40:181\u2013187. doi: 10.1002\/ana.410400209","journal-title":"Ann Neurol"},{"key":"8237_CR2","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1212\/WNL.56.6.758","volume":"56","author":"RD Hadden","year":"2001","unstructured":"Hadden RD, Karch H, Hartung HP et al (2001) Preceding infections, immune factors, and outcome in Guillain\u2013Barr\u00e9 syndrome. Neurology 56:758\u2013765","journal-title":"Neurology"},{"key":"8237_CR3","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1002\/ana.410380516","volume":"38","author":"JH Rees","year":"1995","unstructured":"Rees JH, Gregson NA, Hughes RA (1995) Anti-ganglioside GM1 antibodies in Guillain\u2013Barr\u00e9 syndrome and their relationship to Campylobacter jejuni infection. Ann Neurol 38:809\u2013816. doi: 10.1002\/ana.410380516","journal-title":"Ann Neurol"},{"key":"8237_CR4","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1212\/WNL.58.4.610","volume":"58","author":"R Koningsveld van","year":"2002","unstructured":"van Koningsveld R, Schmitz PIM, Ang CW et al (2002) Infections and course of disease in mild forms of Guillain\u2013Barr\u00e9 syndrome. Neurology 58:610\u2013614","journal-title":"Neurology"},{"key":"8237_CR5","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1016\/S0140-6736(05)67665-9","volume":"366","author":"RA Hughes","year":"2005","unstructured":"Hughes RA, Cornblath DR (2005) Guillain\u2013Barr\u00e9 syndrome. Lancet 366:1653\u20131666","journal-title":"Lancet"},{"key":"8237_CR6","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/nrneurol.2014.121","volume":"10","author":"B Berg van den","year":"2014","unstructured":"van den Berg B, Walgaard C, Drenthen J et al (2014) Guillain\u2013Barr\u00e9 syndrome: pathogenesis, diagnosis, treatment and prognosis. Nat Rev Neurol 10:469\u2013482. doi: 10.1038\/nrneurol.2014.121","journal-title":"Nat Rev Neurol"},{"key":"8237_CR7","doi-asserted-by":"publisher","first-page":"2294","DOI":"10.1056\/NEJMra1114525","volume":"366","author":"N Yuki","year":"2012","unstructured":"Yuki N, Hartung H-P (2012) Guillain\u2013Barr\u00e9 syndrome. N Engl J Med 366:2294\u20132304. doi: 10.1056\/NEJMra1114525","journal-title":"N Engl J Med"},{"key":"8237_CR8","doi-asserted-by":"publisher","first-page":"6517","DOI":"10.1128\/IAI.00967-06","volume":"74","author":"RK Yu","year":"2006","unstructured":"Yu RK, Usuki S, Ariga T (2006) Ganglioside molecular mimicry and its pathological roles in Guillain\u2013Barr\u00e9 syndrome and related diseases. Infect Immun 74:6517\u20136527. doi: 10.1128\/IAI.00967-06","journal-title":"Infect Immun"},{"key":"8237_CR9","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1056\/NEJM199511233332102","volume":"333","author":"JH Rees","year":"1995","unstructured":"Rees JH, Soudain SE, Gregson NA, Hughes RA (1995) Campylobacter jejuni infection and Guillain\u2013Barr\u00e9 syndrome. N Engl J Med 333:1374\u20131379. doi: 10.1056\/NEJM199511233332102","journal-title":"N Engl J Med"},{"key":"8237_CR10","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1136\/jnnp.2010.226639","volume":"82","author":"J Drenthen","year":"2011","unstructured":"Drenthen J, Yuki N, Meulstee J et al (2011) Guillain\u2013Barr\u00e9 syndrome subtypes related to Campylobacter infection. J Neurol Neurosurg Psychiatr 82:300\u2013305. doi: 10.1136\/jnnp.2010.226639","journal-title":"J Neurol Neurosurg Psychiatr"},{"key":"8237_CR11","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1212\/WNL.57.4.736","volume":"57","author":"S Kusunoki","year":"2001","unstructured":"Kusunoki S, Shiina M, Kanazawa I (2001) Anti-Gal-C antibodies in GBS subsequent to mycoplasma infection: evidence of molecular mimicry. Neurology 57:736\u2013738","journal-title":"Neurology"},{"key":"8237_CR12","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0165-5728(02)00209-6","volume":"130","author":"CW Ang","year":"2002","unstructured":"Ang CW, Tio-Gillen AP, Groen J et al (2002) Cross-reactive anti-galactocerebroside antibodies and Mycoplasma pneumoniae infections in Guillain\u2013Barr\u00e9 syndrome. J Neuroimmunol 130:179\u2013183","journal-title":"J Neuroimmunol"},{"key":"8237_CR13","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1002\/1531-8249(200010)48:4<624::AID-ANA9>3.0.CO;2-O","volume":"48","author":"K Ogawara","year":"2000","unstructured":"Ogawara K, Kuwabara S, Mori M et al (2000) Axonal Guillain\u2013Barr\u00e9 syndrome: relation to anti-ganglioside antibodies and Campylobacter jejuni infection in Japan. Ann Neurol 48:624\u2013631","journal-title":"Ann Neurol"},{"key":"8237_CR14","doi-asserted-by":"publisher","first-page":"1880","DOI":"10.3201\/eid1212.051032","volume":"12","author":"CC Tam","year":"2006","unstructured":"Tam CC, O\u2019Brien SJ, Rodrigues LC (2006) Influenza, Campylobacter and Mycoplasma infections, and hospital admissions for Guillain\u2013Barr\u00e9 syndrome, England. Emerg Infect Dis 12:1880\u20131887. doi: 10.3201\/eid1212.051032","journal-title":"Emerg Infect Dis"},{"key":"8237_CR15","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/S0140-6736(77)91626-9","volume":"2","author":"D Adams","year":"1977","unstructured":"Adams D, Gibson JD, Thomas PK et al (1977) HLA antigens in Guillain\u2013Barr\u00e9 syndrome. Lancet 2:504\u2013505","journal-title":"Lancet"},{"key":"8237_CR16","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1212\/WNL.34.2.240","volume":"34","author":"RA Kaslow","year":"1984","unstructured":"Kaslow RA, Sullivan-Bolyai JZ, Hafkin B et al (1984) HLA antigens in Guillain\u2013Barr\u00e9 syndrome. Neurology 34:240. doi: 10.1212\/WNL.34.2.240","journal-title":"Neurology"},{"key":"8237_CR17","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.jneuroim.2006.07.017","volume":"180","author":"PA McCombe","year":"2006","unstructured":"McCombe PA, Csurhes PA, Greer JM (2006) Studies of HLA associations in male and female patients with Guillain\u2013Barr\u00e9 syndrome (GBS) and chronic inflammatory demyelinating polyradiculoneuropathy (CIDP). J Neuroimmunol 180:172\u2013177. doi: 10.1016\/j.jneuroim.2006.07.017","journal-title":"J Neuroimmunol"},{"key":"8237_CR18","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1212\/01.WNL.0000148727.02732.01","volume":"64","author":"K Geleijns","year":"2005","unstructured":"Geleijns K, Schreuder GMT, Jacobs BC et al (2005) HLA class II alleles are not a general susceptibility factor in Guillain\u2013Barre syndrome. Neurology 64:44\u201349. doi: 10.1212\/01.WNL.0000148727.02732.01","journal-title":"Neurology"},{"key":"8237_CR19","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0165-5728(95)00102-8","volume":"62","author":"JH Rees","year":"1995","unstructured":"Rees JH, Vaughan RW, Kondeatis E, Hughes RA (1995) HLA-class II alleles in Guillain\u2013Barr\u00e9 syndrome and Miller Fisher syndrome and their association with preceding Campylobacter jejuni infection. J Neuroimmunol 62:53\u201357","journal-title":"J Neuroimmunol"},{"key":"8237_CR20","doi-asserted-by":"crossref","first-page":"3074","DOI":"10.4049\/jimmunol.170.6.3074","volume":"170","author":"EE Magira","year":"2003","unstructured":"Magira EE, Papaioakim M, Nachamkin I et al (2003) Differential distribution of HLA-DQ beta\/DR beta epitopes in the two forms of Guillain\u2013Barr\u00e9 syndrome, acute motor axonal neuropathy and acute inflammatory demyelinating polyneuropathy (AIDP): identification of DQ beta epitopes associated with susceptibility to and protection from AIDP. J Immunol 170:3074\u20133080","journal-title":"J Immunol"},{"key":"8237_CR21","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/S0140-6736(78)92644-2","volume":"2","author":"RA Hughes","year":"1978","unstructured":"Hughes RA, Newsom-Davis JM, Perkin GD, Pierce JM (1978) Controlled trial prednisolone in acute polyneuropathy. Lancet 2:750\u2013753","journal-title":"Lancet"},{"key":"8237_CR22","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1212\/WNL.54.3.620","volume":"54","author":"R Koningsveld van","year":"2000","unstructured":"van Koningsveld R, van Doorn PA, Schmitz PI et al (2000) Mild forms of Guillain\u2013Barr\u00e9 syndrome in an epidemiologic survey in The Netherlands. Neurology 54:620\u2013625","journal-title":"Neurology"},{"key":"8237_CR23","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1016\/0140-6736(93)90351-G","volume":"341","author":"Guillain\u2013Barr\u00e9 Syndrome Steroid Trial Group","year":"1993","unstructured":"Guillain\u2013Barr\u00e9 Syndrome Steroid Trial Group (1993) Double-blind trial of intravenous methylprednisolone in Guillain\u2013Barr\u00e9 syndrome. Lancet 341:586\u2013590. doi: 10.1016\/0140-6736(93)90351-G","journal-title":"Lancet"},{"key":"8237_CR24","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1046\/j.1468-1331.1999.610071.x","volume":"6","author":"HJ Willison","year":"1999","unstructured":"Willison HJ, Veitch J, Swan AV et al (1999) Inter-laboratory validation of an ELISA for the determination of serum anti-ganglioside antibodies. Eur J Neurol 6:71\u201377","journal-title":"Eur J Neurol"},{"key":"8237_CR25","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.plipres.2009.09.001","volume":"49","author":"S Rinaldi","year":"2010","unstructured":"Rinaldi S, Brennan KM, Willison HJ (2010) Heteromeric glycolipid complexes as modulators of autoantibody and lectin binding. Prog Lipid Res 49:87\u201395. doi: 10.1016\/j.plipres.2009.09.001","journal-title":"Prog Lipid Res"},{"key":"8237_CR26","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.humimm.2011.03.010","volume":"72","author":"AH Schmidt","year":"2011","unstructured":"Schmidt AH, Solloch UV, Pingel J et al (2011) High-resolution human leukocyte antigen allele and haplotype frequencies of the Polish population based on 20,653 stem cell donors. Hum Immunol 72:558\u2013565. doi: 10.1016\/j.humimm.2011.03.010","journal-title":"Hum Immunol"},{"key":"8237_CR27","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1111\/j.1468-1331.2009.02906.x","volume":"17","author":"I Davidson","year":"2010","unstructured":"Davidson I, Wilson C, Walton T et al (2010) What constitutes a \u201cGood\u201d recovery outcome in post-acute Guillain\u2013Barr\u00e9 syndrome? Results of a Nationwide Survey of post-acute GBS sufferers in the United Kingdom. Eur J Neurol 17:677\u2013683. doi: 10.1111\/j.1468-1331.2009.02906.x","journal-title":"Eur J Neurol"},{"key":"8237_CR28","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1136\/jnnp.72.5.596","volume":"72","author":"ISJ Merkies","year":"2002","unstructured":"Merkies ISJ, Schmitz PIM, Van der Mech\u00e9 FGA et al (2002) Clinimetric evaluation of a new overall disability scale in immune mediated polyneuropathies. J Neurol Neurosurg Psychiatr 72:596\u2013601","journal-title":"J Neurol Neurosurg Psychiatr"},{"key":"8237_CR29","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1002\/ana.410440512","volume":"44","author":"RD Hadden","year":"1998","unstructured":"Hadden RD, Cornblath DR, Hughes RA et al (1998) Electrophysiological classification of Guillain\u2013Barr\u00e9 syndrome: clinical associations and outcome. Plasma Exchange\/Sandoglobulin Guillain\u2013Barr\u00e9 Syndrome Trial Group. Ann Neurol 44:780\u2013788. doi: 10.1002\/ana.410440512","journal-title":"Ann Neurol"},{"key":"8237_CR30","doi-asserted-by":"publisher","first-page":"2897","DOI":"10.1093\/brain\/awq260","volume":"133","author":"N Kokubun","year":"2010","unstructured":"Kokubun N, Nishibayashi M, Uncini A et al (2010) Conduction block in acute motor axonal neuropathy. Brain 133:2897\u20132908. doi: 10.1093\/brain\/awq260","journal-title":"Brain"},{"issue":"Suppl 2","key":"8237_CR31","doi-asserted-by":"crossref","first-page":"S125","DOI":"10.1086\/513783","volume":"176","author":"BM Allos","year":"1997","unstructured":"Allos BM (1997) Association between Campylobacter infection and Guillain\u2013Barr\u00e9 syndrome. J Infect Dis 176(Suppl 2):S125\u2013S128","journal-title":"J Infect Dis"},{"key":"8237_CR32","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/j.humimm.2009.08.006","volume":"70","author":"AH Schmidt","year":"2009","unstructured":"Schmidt AH, Baier D, Solloch UV et al (2009) Estimation of high-resolution HLA-A, -B, -C, -DRB1 allele and haplotype frequencies based on 8862 German stem cell donors and implications for strategic donor registry planning. Hum Immunol 70:895\u2013902. doi: 10.1016\/j.humimm.2009.08.006","journal-title":"Hum Immunol"},{"key":"8237_CR33","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1002\/ana.410340208","volume":"34","author":"U Enders","year":"1993","unstructured":"Enders U, Karch H, Toyka KV et al (1993) The spectrum of immune responses to Campylobacter jejuni and glycoconjugates in Guillain\u2013Barr\u00e9 syndrome and in other neuroimmunological disorders. Ann Neurol 34:136\u2013144. doi: 10.1002\/ana.410340208","journal-title":"Ann Neurol"},{"key":"8237_CR34","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1212\/WNL.51.4.1110","volume":"51","author":"BC Jacobs","year":"1998","unstructured":"Jacobs BC, Rothbarth PH, van der Mech\u00e9 FG et al (1998) The spectrum of antecedent infections in Guillain\u2013Barr\u00e9 syndrome: a case\u2013control study. Neurology 51:1110\u20131115","journal-title":"Neurology"},{"key":"8237_CR35","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1159\/000324710","volume":"36","author":"JJ Sejvar","year":"2011","unstructured":"Sejvar JJ, Baughman AL, Wise M, Morgan OW (2011) Population incidence of Guillain\u2013Barr\u00e9 syndrome: a systematic review and meta-analysis. Neuroepidemiology 36:123\u2013133. doi: 10.1159\/000324710","journal-title":"Neuroepidemiology"},{"key":"8237_CR36","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1212\/WNL.43.10.1911","volume":"43","author":"A Chiba","year":"1993","unstructured":"Chiba A, Kusunoki S, Obata H et al (1993) Serum anti-GQ1b IgG antibody is associated with ophthalmoplegia in Miller Fisher syndrome and Guillain\u2013Barr\u00e9 syndrome: clinical and immunohistochemical studies. Neurology 43:1911\u20131917","journal-title":"Neurology"},{"key":"8237_CR37","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1111\/ene.12769","volume":"23","author":"Y Fukami","year":"2016","unstructured":"Fukami Y, Wong AHY, Funakoshi K et al (2016) Anti-GQ1b antibody syndrome: anti-ganglioside complex reactivity determines clinical spectrum. Eur J Neurol 23:320\u2013326. doi: 10.1111\/ene.12769","journal-title":"Eur J Neurol"},{"key":"8237_CR38","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0022-510X(97)00103-2","volume":"151","author":"G Lopate","year":"1997","unstructured":"Lopate G, Pestronk A, Kornberg AJ et al (1997) IgM anti-sulfatide autoantibodies: patterns of binding to cerebellum, dorsal root ganglion and peripheral nerve. J Neurol Sci 151:189\u2013193","journal-title":"J Neurol Sci"},{"key":"8237_CR39","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/S0022-510X(00)00342-7","volume":"176","author":"M Carpo","year":"2000","unstructured":"Carpo M, Meucci N, Allaria S et al (2000) Anti-sulfatide IgM antibodies in peripheral neuropathy. J Neurol Sci 176:144\u2013150","journal-title":"J Neurol Sci"},{"key":"8237_CR40","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1136\/jnnp.56.11.1164","volume":"56","author":"LH Berg van den","year":"1993","unstructured":"van den Berg LH, Lankamp CL, de Jager AE et al (1993) Anti-sulphatide antibodies in peripheral neuropathy. J Neurol Neurosurg Psychiatr 56:1164\u20131168","journal-title":"J Neurol Neurosurg Psychiatr"},{"key":"8237_CR41","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/0022-510X(91)90126-R","volume":"105","author":"AA Ilyas","year":"1991","unstructured":"Ilyas AA, Mithen FA, Dalakas MC et al (1991) Antibodies to sulfated glycolipids in Guillain\u2013Barr\u00e9 syndrome. J Neurol Sci 105:108\u2013117","journal-title":"J Neurol Sci"},{"key":"8237_CR42","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.jneuroim.2007.05.020","volume":"188","author":"N Souayah","year":"2007","unstructured":"Souayah N, Mian NF, Gu Y, Ilyas AA (2007) Elevated anti-sulfatide antibodies in Guillain\u2013Barr\u00e9 syndrome in T cell depleted at end-stage AIDS. J Neuroimmunol 188:143\u2013145. doi: 10.1016\/j.jneuroim.2007.05.020","journal-title":"J Neuroimmunol"},{"key":"8237_CR43","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.gene.2015.05.017","volume":"568","author":"TA Patente","year":"2015","unstructured":"Patente TA, Monteiro MB, Vieira SM et al (2015) Linkage disequilibrium with HLA-DRB1-DQB1 haplotypes explains the association of TNF-308G>A variant with type 1 diabetes in a Brazilian cohort. Gene 568:50\u201354. doi: 10.1016\/j.gene.2015.05.017","journal-title":"Gene"},{"key":"8237_CR44","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/0091-6749(94)90386-7","volume":"93","author":"C Tautz","year":"1994","unstructured":"Tautz C, Rihs HP, Thiele A et al (1994) Association of class II sequences encoding DR1 and DQ5 specificities with hypersensitivity to chironomid allergen Chi t I. J Allergy Clin Immunol 93:918\u2013925","journal-title":"J Allergy Clin Immunol"},{"key":"8237_CR45","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.clineuro.2014.03.014","volume":"121","author":"N Fekih-Mrissa","year":"2014","unstructured":"Fekih-Mrissa N, Mrad M, Riahi A et al (2014) Association of HLA-DR\/DQ polymorphisms with Guillain\u2013Barr\u00e9 syndrome in Tunisian patients. Clin Neurol Neurosurg 121:19\u201322. doi: 10.1016\/j.clineuro.2014.03.014","journal-title":"Clin Neurol Neurosurg"},{"key":"8237_CR46","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1111\/j.1365-2222.2004.1956.x","volume":"34","author":"MG Jones","year":"2004","unstructured":"Jones MG, Nielsen J, Welch J et al (2004) Association of HLA-DQ5 and HLA-DR1 with sensitization to organic acidanhydrides. Clin Exp Allergy 34:812\u2013816. doi: 10.1111\/j.1365-2222.2004.1956.x","journal-title":"Clin Exp Allergy"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-016-8237-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-016-8237-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-016-8237-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T15:44:09Z","timestamp":1498319049000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-016-8237-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,2]]},"references-count":46,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["8237"],"URL":"https:\/\/doi.org\/10.1007\/s00415-016-8237-6","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,2]]}}}